Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial
DRKS00016915Phase 3Completed
- Sponsor
- SickKids
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised trial of digoxin, sotalol and flecainide in atrial flutter (AFL), supraventricular tachycardia (SVT), Hydrops fetalis (HF) and 2 more (6 arms), sponsored by SickKids. Started Apr 2019; status: completed.
02
Drugs
digoxinsotalolflecainide
03
Conditions
atrial flutter (AFL)supraventricular tachycardia (SVT)Hydrops fetalis (HF)atrial fibrillation and atrial flutterparoxysmal supraventricular tachycardia (PSVT)
Beyond the preview
Go deeper on DRKS00016915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00016915.